Drawing for SUN TECH

USPTO serial 77147026

SUN TECH

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SETTLES LEWIS, SHAILA E
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SUN TECH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Robert M. Schwartz

ROBERT M. SCHWARTZ ROBERT M. SCHWARTZ, P.A.PO BOX 221470HOLLYWOOD, FL 33022-1470UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003Sunscreen and suntan lotions and oils, after tan skin lotions and gels; Sunscreen ingredients sold as a component of sunscreen preparations, namely, Octinoxate, Octisalate, Oxybenzone, Parsol 1789, Zinc Oxide and Titanium DioxideACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Nov 17, 2008MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 17, 2008ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 15, 2008NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 22, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 2, 2008NPUBNOTICE OF PUBLICATION—
Dec 20, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 29, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 29, 2007ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Oct 5, 2007PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Sep 22, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 17, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 8, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 22, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 22, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 28, 2007CEPECOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED—
Jul 28, 2007ALIEASSIGNED TO LIE—
Jul 20, 2007GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jul 20, 2007GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jul 20, 2007CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Jul 17, 2007DOCKASSIGNED TO EXAMINER—
Apr 6, 2007NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance